Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Randomized feeding intervention in infants at high risk for celiac disease.

Vriezinga SL, Auricchio R, Bravi E, Castillejo G, Chmielewska A, Crespo Escobar P, Kolaček S, Koletzko S, Korponay-Szabo IR, Mummert E, Polanco I, Putter H, Ribes-Koninckx C, Shamir R, Szajewska H, Werkstetter K, Greco L, Gyimesi J, Hartman C, Hogen Esch C, Hopman E, Ivarsson A, Koltai T, Koning F, Martinez-Ojinaga E, te Marvelde C, Pavic A, Romanos J, Stoopman E, Villanacci V, Wijmenga C, Troncone R, Mearin ML.

N Engl J Med. 2014 Oct 2;371(14):1304-15. doi: 10.1056/NEJMoa1404172.

2.

Injection of celiac disease patient sera or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease.

Kalliokoski S, Caja S, Frias R, Laurila K, Koskinen O, Niemelä O, Mäki M, Kaukinen K, Korponay-Szabó IR, Lindfors K.

J Mol Med (Berl). 2015 Jan;93(1):51-62. doi: 10.1007/s00109-014-1204-8. Epub 2014 Sep 12.

PMID:
25209899
3.

Autoantibodies and CD: past and future of celiac antibody testing.

Korponay-Szabó IR.

J Pediatr Gastroenterol Nutr. 2014 Jul;59 Suppl 1:S11-3. doi: 10.1097/01.mpg.0000450395.68897.c1.

PMID:
24979192
4.

Celiac disease: past, present, and future challenges: dedicated to the memory of our friend and colleague, Prof David Branski (1944-2013).

Shamir R, Heyman MB, Koning F, Wijimenga C, Gutierrez-Achury J, Catassi C, Gatti S, Fasano A, Discepolo V, Korponay-Szabó IR, Zevit N, Maki M, Schaart MW, Mearin ML, Troncone R.

J Pediatr Gastroenterol Nutr. 2014 Jul;59 Suppl 1:S1-20. doi: 10.1097/MPG.0000000000000410. No abstract available.

PMID:
24840514
5.

Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.

Antonella Nadalutti C, Korponay-Szabo IR, Kaukinen K, Wang Z, Griffin M, Mäki M, Lindfors K.

PLoS One. 2013 Oct 9;8(10):e77277. doi: 10.1371/journal.pone.0077277. eCollection 2013.

6.

Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.

Nadalutti CA, Korponay-Szabo IR, Kaukinen K, Griffin M, Mäki M, Lindfors K.

Cell Mol Life Sci. 2014 Apr;71(7):1315-26. doi: 10.1007/s00018-013-1455-5. Epub 2013 Aug 28.

PMID:
23982754
7.

Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.

Kalliokoski S, Sulic AM, Korponay-Szabó IR, Szondy Z, Frias R, Perez MA, Martucciello S, Roivainen A, Pelliniemi LJ, Esposito C, Griffin M, Sblattero D, Mäki M, Kaukinen K, Lindfors K, Caja S.

PLoS One. 2013 Jun 18;8(6):e65887. Print 2013.

8.

Gluten-dependent intestinal autoimmune response.

Korponay-Szabó IR, Simon-Vecsei Z, De Leo L, Not T.

Curr Pharm Des. 2012;18(35):5753-8. Review.

PMID:
22726113
9.

Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.

Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S, Korponay-Szabó IR; ESPGHAN Working Group on Coeliac Disease Diagnosis.

J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):229-41. doi: 10.1097/MPG.0b013e318216f2e5. Review.

PMID:
22266486
10.

A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.

Simon-Vecsei Z, Király R, Bagossi P, Tóth B, Dahlbom I, Caja S, Csosz É, Lindfors K, Sblattero D, Nemes É, Mäki M, Fésüs L, Korponay-Szabó IR.

Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):431-6. doi: 10.1073/pnas.1107811108. Epub 2011 Dec 22.

11.

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.

Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Mäki M, Ribes-Koninckx C, Ventura A, Zimmer KP; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60. doi: 10.1097/MPG.0b013e31821a23d0. Erratum in: J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):572.

PMID:
22197856
12.

Genome-wide analysis of extended pedigrees confirms IL2-IL21 linkage and shows additional regions of interest potentially influencing coeliac disease risk.

Einarsdottir E, Koskinen LL, de Kauwe AL, Dukes E, Mustalahti K, Balogh M, Korponay-Szabo IR, Kaukinen K, Kurppa K, Adány R, Pocsai Z, Széles G, Mäki M, Kere J, Saavalainen P.

Tissue Antigens. 2011 Dec;78(6):428-37. doi: 10.1111/j.1399-0039.2011.01791.x.

PMID:
22077623
13.

Coeliac disease diagnosis: ESPGHAN 1990 criteria or need for a change? Results of a questionnaire.

Ribes-Koninckx C, Mearin ML, Korponay-Szabó IR, Shamir R, Husby S, Ventura A, Branski D, Catassi C, Koletzko S, Mäki M, Troncone R, Zimmer KP; ESPGHAN Working Group on Coeliac Disease Diagnosis.

J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):15-9. doi: 10.1097/MPG.0b013e31822a00bb.

PMID:
21716133
14.

Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations.

Einarsdottir E, Bevova MR, Zhernakova A, Monsuur A, Koskinen LL, van't Slot R, Mulder C, Mearin ML, Korponay-Szabo IR, Kaukinen K, Kurppa K, Kere J, Mäki M, Wijmenga C, Saavalainen P.

Eur J Hum Genet. 2011 Jun;19(6):682-6. doi: 10.1038/ejhg.2011.2. Epub 2011 Feb 16.

15.

Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.

Rauhavirta T, Qiao SW, Jiang Z, Myrsky E, Loponen J, Korponay-Szabó IR, Salovaara H, Garcia-Horsman JA, Venäläinen J, Männistö PT, Collighan R, Mongeot A, Griffin M, Mäki M, Kaukinen K, Lindfors K.

Clin Exp Immunol. 2011 Apr;164(1):127-36. doi: 10.1111/j.1365-2249.2010.04317.x. Epub 2011 Jan 14.

16.

Increased heat shock protein 72 expression in celiac disease.

Sziksz E, Veres G, Vannay A, Prókai A, Gál K, Onody A, Korponay-Szabó IR, Reusz G, Szabó A, Tulassay T, Arató A, Szebeni B.

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):573-8. doi: 10.1097/MPG.0b013e3181ea0092.

PMID:
20818265
17.

Increased expression of hypoxia-inducible factor 1alpha in coeliac disease.

Vannay A, Sziksz E, Prókai A, Veres G, Molnár K, Szakál DN, Onódy A, Korponay-Szabó IR, Szabó A, Tulassay T, Arató A, Szebeni B.

Pediatr Res. 2010 Aug;68(2):118-22. doi: 10.1203/00006450-201011001-00227.

PMID:
20453713
18.

Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.

Caja S, Myrsky E, Korponay-Szabo IR, Nadalutti C, Sulic AM, Lavric M, Sblattero D, Marzari R, Collighan R, Mongeot A, Griffin M, Mäki M, Kaukinen K, Lindfors K.

Scand J Gastroenterol. 2010 Apr;45(4):421-7. doi: 10.3109/00365520903540822.

PMID:
20095873
19.

Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.

Hodrea J, Demény MA, Majai G, Sarang Z, Korponay-Szabó IR, Fésüs L.

Immunol Lett. 2010 May 4;130(1-2):74-81. doi: 10.1016/j.imlet.2009.12.010. Epub 2010 Feb 10.

PMID:
20005901
20.

Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.

Király R, Csosz E, Kurtán T, Antus S, Szigeti K, Simon-Vecsei Z, Korponay-Szabó IR, Keresztessy Z, Fésüs L.

FEBS J. 2009 Dec;276(23):7083-96. doi: 10.1111/j.1742-4658.2009.07420.x. Epub 2009 Oct 29.

PMID:
19878304
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk